View in EDS

Preventing physical and chemical degradation of the LABL-Fc-MOGR5, a bifunctional peptide inhibitor, with formulation development approaches.

Saved in:
Bibliographic Details
Title: Preventing physical and chemical degradation of the LABL-Fc-MOGR5, a bifunctional peptide inhibitor, with formulation development approaches.
Authors: Xin L; BioDev Department, WuXi Biologics USA, Cranbury, NJ 08512, United States.; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, United States., Mahadik R; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, United States., Prorok M; BioDev Department, WuXi Biologics USA, Cranbury, NJ 08512, United States., Rodriguez MS; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, United States., Chan KQ; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, United States., Tolbert T; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, United States., Li Y; BioDev Department, WuXi Biologics USA, Cranbury, NJ 08512, United States., Siahaan TJ; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, United States.
Source: Antibody therapeutics [Antib Ther] 2026 Feb 24; Vol. 9 (3), pp. 215-229. Date of Electronic Publication: 2026 Feb 24 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 101730822 Publication Model: eCollection Cited Medium: Internet ISSN: 2516-4236 (Electronic) Linking ISSN: 25164236 NLM ISO Abbreviation: Antib Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42382974
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Preventing physical and chemical degradation of the LABL-Fc-MOG<subscript>R5</subscript>, a bifunctional peptide inhibitor, with formulation development approaches.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Xin+L%22">Xin L</searchLink>; BioDev Department, WuXi Biologics USA, Cranbury, NJ 08512, United States.; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, United States.<br /><searchLink fieldCode="AU" term="%22Mahadik+R%22">Mahadik R</searchLink>; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, United States.<br /><searchLink fieldCode="AU" term="%22Prorok+M%22">Prorok M</searchLink>; BioDev Department, WuXi Biologics USA, Cranbury, NJ 08512, United States.<br /><searchLink fieldCode="AU" term="%22Rodriguez+MS%22">Rodriguez MS</searchLink>; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, United States.<br /><searchLink fieldCode="AU" term="%22Chan+KQ%22">Chan KQ</searchLink>; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, United States.<br /><searchLink fieldCode="AU" term="%22Tolbert+T%22">Tolbert T</searchLink>; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, United States.<br /><searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; BioDev Department, WuXi Biologics USA, Cranbury, NJ 08512, United States.<br /><searchLink fieldCode="AU" term="%22Siahaan+TJ%22">Siahaan TJ</searchLink>; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101730822%22">Antibody therapeutics</searchLink> [Antib Ther] 2026 Feb 24; Vol. 9 (3), pp. 215-229. <i>Date of Electronic Publication: </i>2026 Feb 24 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101730822 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2516-4236 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225164236%22">25164236 </searchLink><i>NLM ISO Abbreviation: </i>Antib Ther <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42382974
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/abt/tbag005
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 215
    Titles:
      – TitleFull: Preventing physical and chemical degradation of the LABL-Fc-MOGR5, a bifunctional peptide inhibitor, with formulation development approaches.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Xin L
      – PersonEntity:
          Name:
            NameFull: Mahadik R
      – PersonEntity:
          Name:
            NameFull: Prorok M
      – PersonEntity:
          Name:
            NameFull: Rodriguez MS
      – PersonEntity:
          Name:
            NameFull: Chan KQ
      – PersonEntity:
          Name:
            NameFull: Tolbert T
      – PersonEntity:
          Name:
            NameFull: Li Y
      – PersonEntity:
          Name:
            NameFull: Siahaan TJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 02
              Text: 2026 Feb 24
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2516-4236
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Antibody therapeutics
              Type: main
ResultId 1